The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
The role of toxins in Clostridium difficile infection
Open accessAbstract
Clostridium difficile is a bacterial pathogen that is the leading cause of nosocomial antibiotic-associated diarrhea and pseudomembranous colitis worldwide. The incidence, severity, mortality and healthcare costs associated with C. difficile infection (CDI) are rising, making C. difficile a major threat to public health. Traditional treatments for CDI involve use of antibiotics such as metronidazole and vancomycin, but disease recurrence occurs in about 30% of patients, highlighting the need for new therapies. The pathogenesis of C. difficile is primarily mediated by the actions of two large clostridial glucosylating toxins, toxin A (TcdA) and toxin B (TcdB). Some strains produce a third toxin, the binary toxin C. difficile transferase, which can also contribute to C. difficile virulence and disease. These toxins act on the colonic epithelium and immune cells and induce a complex cascade of cellular events that result in fluid secretion, inflammation and tissue damage, which are the hallmark features of the disease. In this review, we summarize our current understanding of the structure and mechanism of action of the C. difficile toxins and their role in disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–324 of 324
A novel regulator controls C lostridium difficile sporulation, motility and toxin production
Edwards, A. N., Tamayo, R., & McBride, S. M. (2016) · Molecular Microbiology · doi:10.1111/mmi.13361 · Cited by 97
Clostridium difficile Glucosyltransferase Toxin B-essential Amino Acids for Substrate Binding
Jank, T., Giesemann, T., & Aktories, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703138200 · Cited by 96
Kim, H., Kokkotou, E. G., Na, X., Rhee, S. H., Moyer, M. P., Pothoulakis, C., & LaMont, J. T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.011 · Cited by 96
Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum
Pothoulakis, C., Karmeli, F., Kelly, C. P., Eliakim, R., Joshi, M. A., O'Keane, C. J., Castagliuolo, I., LaMont, J. T., & Rachmilewitz, D. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90886-h · Cited by 95
Karlsson, S., Dupuy, B., Mukherjee, K., Norin, E. L., BURMAN, L. G., & Åkerlund, T. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1784-1793.2003 · Cited by 94
Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins
Savidge, T., Urvil, P., Oezguen, N., Ali, K., Choudhury, A., Acharya, V., Pinchuk, I., Torres, A. G., English, R. D., Wiktorowicz, J. E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2405 · Cited by 92
Hamm, E. E., Voth, D. E., & Ballard, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604725103 · Cited by 92
Sun, X., & Hirota, S. A. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.09.005 · Cited by 91
CdtR Regulates TcdA and TcdB Production in Clostridium difficile
Lyon, S. A., Hutton, M. L., Rood, J. I., Cheung, J. K., & Lyras, D. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005758 · Cited by 91
Cholesterol-dependent Pore Formation of Clostridium difficile Toxin A
Giesemann, T., Jank, T., Gerhard, R., Maier, E., Just, I., Benz, R., & Aktories, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512720200 · Cited by 90
Positive regulation of Clostridium difficile toxins
Moncrief, J. S., Barroso, L. A., & Wilkins, T. D. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.1105-1108.1997 · Cited by 90
IL-8 release and neutrophil activation byClostridium difficiletoxin-exposed human monocytes
Linevsky, J. K., Pothoulakis, C., Keates, S. E., Warny, M., Keates, A. C., LaMont, J. T., & Kelly, C. P. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.6.g1333 · Cited by 90
Kaiser, E., Kroll, C., Ernst, K., Schwan, C., Popoff, M. R., Fischer, G. S., Büchner, J., Aktories, K., & Barth, H. (2011) · Infection and Immunity · doi:10.1128/iai.05372-11 · Cited by 90
NEONATAL SCREENING FOR CYSTIC FIBROSIS
Dankert-Roelse, J. E., Meerman, G. J. T., Cornel, M. C., Knol, K., & ten Kate, L. P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91812-x · Cited by 88
Functional Consequences of Monoglucosylation of Ha-Ras at Effector Domain Amino Acid Threonine 35
Herrmann, C., Ahmadian, M. R., Hofmann, F., & Just, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16134 · Cited by 88
Cellular Uptake of the Clostridium perfringens Binary Iota-Toxin
Blöcker, D., Behlke, J., Aktories, K., & Barth, H. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2980-2987.2001 · Cited by 84
Structural determinants of Clostridium difficile toxin A glucosyltransferase activity
Pruitt, R. N., Chumbler, N. M., Rutherford, S. A., Farrow, M. A., Friedman, D. B., Spiller, B., & Lacy, D. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298414 · Cited by 83
Self-citationRole of Interleukin 23 Signaling in Clostridium difficile Colitis
Buonomo, E. L., Madan, R., Pramoonjago, P., Li, L., Okusa, M. D., & Petri, W. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit277 · Cited by 83
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A
Gardiner, D., Rosenberg, T., Zaharatos, G. J., Franco, D., & Ho, D. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.058 · Cited by 82
Jafari, N. V., Kuehne, S. A., Bryant, C. E., Elawad, M., Wren, B. W., Minton, N. P., Allan, E., & Bajaj‐Elliott, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069846 · Cited by 81
Mahida, Y. R., Galvin, A., Makh, S., et al. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5462-5469.1998 · Cited by 81
Mesli, S., Javorschi, S., Bérard, A. M., Landry, M., Priddle, H., Kivlichan, D., Smith, A. J. H., Yen, F. T., Bihain, B. E., & Darmon, M. Y. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04223.x · Cited by 80
Cowardin, C. A., Kuehne, S. A., Buonomo, E. L., Marie, C. S., Minton, N. P., & Petri, W. A. (2015) · mBio · doi:10.1128/mbio.02386-14 · Cited by 80
Jefferson, K. K., Smith, M. F., & Bobak, D. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5183 · Cited by 79
Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion
Govind, R., Fitzwater, L., & Nichols, R. (2015) · Journal of Bacteriology · doi:10.1128/jb.00224-15 · Cited by 78
Small Molecule Inhibitors of Clostridium difficile Toxin B-Induced Cellular Damage
Tam, J., Beilhartz, G. L., Auger, A., Gupta, P., Therien, A. G., & Melnyk, R. A. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.12.010 · Cited by 78
Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.
Kurose, I., Pothoulakis, C., LaMont, J. T., Anderson, D. C., Paulson, J. C., Miyasaka, M., Wolf, R., & Granger, D. N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117542 · Cited by 76
Geissler, B., Tungekar, R., & Satchell, K. J. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908700107 · Cited by 76
Nottrott, S., Schoentaube, J., Genth, H., Just, I., & Gerhard, R. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0074-8 · Cited by 73
Dingle, T. C., Wee, S., Mulvey, G. L., Greco, A., Kitova, E. N., Sun, J., Lin, S., Klassen, J. S., Palcic, M. M., Ng, K. K.-S., et al. (2008) · Glycobiology · doi:10.1093/glycob/cwn048 · Cited by 73
Interaction of Clostridium perfringensIota-Toxin with Lipid Bilayer Membranes
Knapp, O., Benz, R., Gibert, M., Marvaud, J., & Popoff, M. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103939200 · Cited by 72
Kim, J. M., Lee, J., Yoon, Y. M., Oh, Y., Youn, J., & Kim, Y. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.001756.x · Cited by 72
Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms
Chumbler, N. M., Farrow, M. A., Lapierre, L. A., Franklin, J. L., & Lacy, D. B. (2016) · Infection and Immunity · doi:10.1128/iai.00583-16 · Cited by 72
Self-citationOlling, A., Goy, S., Hoffmann, F., Tatge, H., Just, I., & Gerhard, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017623 · Cited by 71
Kaiser, E., Pust, S., Kroll, C., & Barth, H. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01291.x · Cited by 71
Human intestinal epithelial and smooth muscle cells are potent producers of IL‐6
Ng, E. K., Panesar, N. K., Longo, W. E., Shapiro, M. J., Kaminski, D. L., Tolman, K. C., & Mazuski, J. E. (2003) · Mediators of Inflammation · doi:10.1080/0962935031000096917 · Cited by 71
Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins
Shen, A., Lupardus, P. J., Gersch, M., Puri, A. W., Albrow, V. E., García, K. C., & Bogyo, M. S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1990 · Cited by 71
Enteric glial cells are susceptible to Clostridium difficile toxin B
Fettucciari, K., Ponsini, P., Gioè, D., Macchioni, L., Palumbo, C., Antonelli, E., Coaccioli, S., Villanacci, V., Corazzi, L., Marconi, P., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2426-4 · Cited by 70
The Host Cell Chaperone Hsp90 Is Necessary for Cytotoxic Action of the Binary Iota-Like Toxins
Haug, G., Aktories, K., & Barth, H. (2004) · Infection and Immunity · doi:10.1128/iai.72.5.3066-3068.2004 · Cited by 69
Zhang, Z., Park, M., Tam, J., Auger, A., Beilhartz, G. L., Lacy, D. B., & Melnyk, R. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400680111 · Cited by 69
Self-citationRepurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
Thangamani, S., Younis, W., & Seleem, M. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133877 · Cited by 68
Conformational Changes and Reaction of Clostridial Glycosylating Toxins
Ziegler, M. O. P., Jank, T., Aktories, K., & Schulz, G. E. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.12.065 · Cited by 68
Rocha, M. F. G., Maia, M. E. S., Bezerra, L. R., Lyerly, D. M., Guerrant, R. L., Ribeiro, R. A., & Lima, A. Â. M. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2740-2746.1997 · Cited by 68
Puri, A. W., Lupardus, P. J., Deu, E., Albrow, V. E., García, K. C., Bogyo, M. S., & Shen, A. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.09.011 · Cited by 67
Clostridium difficileToxins A and B Directly Stimulate Human Mast Cells
Meyer, G. K. A., Neetz, A., Brandes, G., Tsikas, D., Butterfield, J. H., Just, I., & Gerhard, R. (2007) · Infection and Immunity · doi:10.1128/iai.00195-07 · Cited by 67
Wohlan, K., Goy, S., Olling, A., Srivaratharajan, S., Tatge, H., Genth, H., & Gerhard, R. (2014) · Cellular Microbiology · doi:10.1111/cmi.12317 · Cited by 66
Hansen, A., Alston, L. A., Tulk, S. E., Schenck, L. P., Grassie, M. E., Alhassan, B., Veermalla, A., Bashir, S. M. A., Gendron, F., Altier, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081491 · Cited by 66
Anton, P. M., Gay, J., Mykoniatis, A., Pan, A., O’Brien, M. J., Brown, D., Karalis, K. P., & Pothoulakis, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402693101 · Cited by 65
Soehn, F., Wagenknecht-Wiesner, A., Leukel, P., Kohl, M., Weidmann, M., von Eichel-Streiber, C., & Braun, V. (1998) · Molecular and General Genetics MGG · doi:10.1007/s004380050726 · Cited by 64
Busch, C., Hofmann, F., Gerhard, R., & Aktories, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13228 · Cited by 64
McDermott, A. J., Falkowski, N. R., McDonald, R. A., Pandit, C. R., Young, V. B., & Huffnagle, G. B. (2015) · Immunology · doi:10.1111/imm.12545 · Cited by 63
Genth, H., Pauillac, S., Schelle, I., Bouvet, P., Bouchier, C., Chavez, C. V., Just, I., & Popoff, M. R. (2014) · Cellular Microbiology · doi:10.1111/cmi.12321 · Cited by 62
Schwan, C., Nölke, T., Kruppke, A. S., Schubert, D. M., Lang, A. E., & Aktories, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261925 · Cited by 62
Sauerborn, M., Leukel, P., & von Eichel‐Streiber, C. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb12684.x · Cited by 62
CD44 Promotes Intoxication by the Clostridial Iota-Family Toxins
Wigelsworth, D. J., Ruthel, G. T., Schnell, L., Herrlich, P. A., Blonder, J., Veenstra, T. D., Carman, R. J., Wilkins, T. D., Nhieu, G. T. V., Pauillac, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051356 · Cited by 61
Sundriyal, A., Roberts, A. K., Shone, C. C., & Acharya, K. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043018 · Cited by 60
Clostridium perfringens TpeL Glycosylates the Rac and Ras Subfamily Proteins
Nagahama, M., Ohkubo, A., Oda, M., Kobayashi, K., AMIMOTO, K., Miyamoto, K., & Sakùrai, J. (2010) · Infection and Immunity · doi:10.1128/iai.01019-10 · Cited by 60
Gupta, P., Zhang, Z., Sugiman‐Marangos, S. N., Tam, J., Raman, S., Julien, J., Kroh, H. K., Lacy, D. B., Murgolo, N., Bekkari, K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806687 · Cited by 60
Self-citationSun, X., He, X., Tzipori, S. R., Gerhard, R., & Feng, H. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.03.002 · Cited by 55
Hirota, S. A., Iablokov, V., Tulk, S. E., Schenck, L. P., Becker, H. M., Nguyen, J., Bashir, S. M. A., Dingle, T. C., Laing, A., Liu, P. J., et al. (2012) · Infection and Immunity · doi:10.1128/iai.00933-12 · Cited by 55
MAPK-Activated Protein Kinase 2 Contributes to Clostridium difficile-Associated Inflammation
Bobo, L. D., Feghaly, R. E. E., Chen, Y.-S., Dubberke, E. R., Han, Z., Baker, A. H., Li, J., Burnham, C. D., & Haslam, D. B. (2012) · Infection and Immunity · doi:10.1128/iai.00186-12 · Cited by 55
Pore-forming activity of clostridial binary toxins
Knapp, O., Benz, R., & Popoff, M. R. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.08.006 · Cited by 55
Allosteric regulation of protease activity by small molecules
Shen, A. (2010) · Molecular BioSystems · doi:10.1039/c003913f · Cited by 54
Feltis, B. A., Wiesner, S. M., Kim, A. S., Erlandsen, S. L., Lyerly, D. L., Wilkins, T. D., & Wells, C. L. (2000) · Shock · doi:10.1097/00024382-200014060-00010 · Cited by 53
Alcantara, C., Stenson, W. F., Steiner, T. S., & Guerrant, R. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/322799 · Cited by 53
Brito, G. A. D. C., Carneiro‐Filho, B. A., Oriá, R. B., Destura, R. V., Lima, A. Â. M., & Guerrant, R. L. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2771-x · Cited by 52
Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains
Stare, B. G., Delmée, M., & Rupnik, M. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46931-0 · Cited by 52
Neunlist, M., Barouk, J., Michel, K., Just, I., Oreshkova, T., Schemann, M., & Galmiche, J. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00487.2002 · Cited by 51
Na, X., Zhao, D., Koon, H. W., Kim, H., Husmark, J., Moyer, M. P., Pothoulakis, C., & LaMont, J. T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.053 · Cited by 51
Tixier, E., Lalanne, F., Just, I., Galmiche, J., & Neunlist, M. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00596.x · Cited by 51
Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A
Kreimeyer, I., Euler, F., Marckscheffel, A., Tatge, H., Pich, A., Olling, A., Schwarz, J., Just, I., & Gerhard, R. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0574-x · Cited by 50
Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile
Hong, H. A., Hitri, K., Hosseini, S., Kotowicz, N. K., Bryan, D., Mawas, F., Wilkinson, A. J., Broekhoven, A. V., Kearsey, J., & Cutting, S. M. (2017) · Infection and Immunity · doi:10.1128/iai.01060-16 · Cited by 50
Lyerly, D. M., Johnson, J. L., Frey, S. M., & Wilkins, T. D. (1990) · Current Microbiology · doi:10.1007/bf02090096 · Cited by 49
Clostridium difficile Toxin A Undergoes Clathrin-Independent, PACSIN2-Dependent Endocytosis
Chandrasekaran, R., Kenworthy, A. K., & Lacy, D. B. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006070 · Cited by 49
Self-citationTerada, N., Ohno, N., Murata, S., Katoh, R., Stallcup, W. B., & Ohno, S. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0184-3 · Cited by 48
Papatheodorou, P., Hornuß, D., Nölke, T., Hemmasi, S., Castonguay, J., Picchianti, M., & Aktories, K. (2013) · mBio · doi:10.1128/mbio.00244-13 · Cited by 48
Hale, M. L., Marvaud, J., Popoff, M. R., & Stiles, B. G. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2186-2193.2004 · Cited by 48
Binding of Clostridium difficile toxins to human milk oligosaccharides
El-Hawiet, A., Kitova, E. N., Kitov, P. I., Eugenio, L., Ng, K. K.-S., Mulvey, G. L., Dingle, T. C., Szpacenko, A., Armstrong, G. D., & Klassen, J. S. (2011) · Glycobiology · doi:10.1093/glycob/cwr055 · Cited by 47
Qiu, B., Pothoulakis, C., Castagliuolo, I., Nikulásson, S. Þ., & LaMont, J. T. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.2.g485 · Cited by 47
New and emerging therapies for Clostridium difficile infection
Martin, J. S. H., & Wilcox, M. H. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000320 · Cited by 47
Hemmasi, S., Czulkies, B. A., Schorch, B., Veit, A., Aktories, K., & Papatheodorou, P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650523 · Cited by 46
Effects of Toxin A from Clostridium difficile on Mast Cell Activation and Survival
Calderón, G. M., Torres-López, J., Lin, T., Chávez, B., Hernández, M. H., Muñoz, O., Befus, A. D., & Enciso, J. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2755-2761.1998 · Cited by 46
Kirkwood, K. S., Bunnett, N. W., Maa, J., Castagliolo, I., Liu, B., Gerard, N. P., Zacks, J., Pothoulakis, C., & Grady, E. F. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.2.g544 · Cited by 46
Mantyh, C. R., Maggio, J. E., Mantyh, P. W., Vigna, S. R., & Pappas, T. N. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02282350 · Cited by 46
Androga, G. O., Hart, J., Foster, N. F., CHARLES, A. K., Forbes, D., & Riley, T. V. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01810-15 · Cited by 45
Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile
Aldape, M. J., Packham, A. E., Nute, D. W., Bryant, A. E., & Stevens, D. L. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.056218-0 · Cited by 45
Lee, J., Park, H., Oh, Y., Kim, Y.-J., Youn, J., Han, J., & Kim, J. M. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0237-7 · Cited by 45
Effect of Arginine on Toxin Production by Clostridium difficile in Defined Medium
Karasawa, T., Maegawa, T., Nojiri, T., Yamakawa, K., & Nakamura, S. (1997) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1997.tb01895.x · Cited by 45
Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments
Leuzzi, R., Spencer, J., Buckley, A. M., Brettoni, C., Martinelli, M., Tulli, L., Marchi, S., Luzzi, E., Irvine, J. J., Candlish, D., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01341-12 · Cited by 45
Geissler, B., Ahrens, S., & Satchell, K. J. F. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01718.x · Cited by 44
Ernst, K., Langer, S., Kaiser, E., Osseforth, C., Michaelis, J., Popoff, M. R., Schwan, C., Aktories, K., Kahlert, V., Malešević, M., et al. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.013 · Cited by 44
de Souza, M. H. L. P., Filho, A. A. M., Rocha, M. F. G., Lyerly, D. M., Cunha, F. Q., Lima, A. Â. M., & RIBEIRO, R. A. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00243.x · Cited by 44
Quesada-Gómez, C., López‐Ureña, D., Chumbler, N. M., Kroh, H. K., Castro-Peña, C., Rodríguez, C., Orozco-Aguilar, J., González-Camacho, S., Rucavado, A., Guzmán‐Verri, C., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01291-15 · Cited by 43
Self-citationErnst, K., Schmid, J., Beck, M., Hägele, M., Hohwieler, M., Hauff, P., Ückert, A., Anastasia, A., Fauler, M., Jank, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02882-y · Cited by 43
Jank, T., Reinert, D. J., Giesemann, T., Schulz, G. E., & Aktories, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506836200 · Cited by 42
Hernandez, L. D., Kroh, H. K., Hsieh, E. J., Yang, X., Beaumont, M., Sheth, P. R., DiNunzio, E. N., Rutherford, S. A., Ohi, M. D., Ermakov, G., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.02.010 · Cited by 42
Self-citationMonaghan, T. M., Robins, A., Knox, A. J., Sewell, H. F., & Mahida, Y. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074452 · Cited by 41
Sundriyal, A., Roberts, A. K., Ling, R., McGlashan, J., Shone, C. C., & Acharya, K. R. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.04.014 · Cited by 40
Macchioni, L., Davidescu, M., Fettucciari, K., Petricciuolo, M., Gatticchi, L., Gioè, D., Villanacci, V., Bellini, M., Marconi, P., Roberti, R., et al. (2017) · Scientific Reports · doi:10.1038/srep45569 · Cited by 39
Elliott, B., Reed, R. P., Chang, B. J., & Riley, T. V. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.08.006 · Cited by 38
Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain
Gerhard, R., Frenzel, E., Goy, S., & Olling, A. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.057828-0 · Cited by 38
Variant toxin B and a functional toxin A produced by Clostridium difficile C34
Mehlig, M., Moos, M., Braun, V., Kalt, B., Mahony, D. E., & von Eichel‐Streiber, C. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10638.x · Cited by 36
Baliban, S. M., Michael, A., Shammassian, B. H., Mudakha, S., Khan, A. S., Cocklin, S., Zentner, I., Latimer, B. P., Bouillaut, L., Hunter, M., et al. (2014) · Infection and Immunity · doi:10.1128/iai.01950-14 · Cited by 36
Li, S., Shi, L., Yang, Z., & Feng, H. (2012) · Pathogens and Disease · doi:10.1111/2049-632x.12016 · Cited by 35
Critical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis
Li, S., Shi, L., Yang, Z., Zhang, Y., Pérez‐Cordón, G., Huang, T., Ramsey, J. P., Oezguen, N., Savidge, T., & Feng, H. (2014) · Infection and Immunity · doi:10.1128/iai.02316-14 · Cited by 35
Effect of Clindamycin on Cytotoxin Production by Clostridium difficile
Nakamura, S., 三川, 正., Tanabe, N., Yamakawa, K., & Nishida, S. (1982) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1982.tb00248.x · Cited by 34
Binding and entry of Clostridium difficile toxin B is mediated by multiple domains
Manse, J. S., & Baldwin, M. R. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.11.017 · Cited by 34
Geyer, M., Wilde, C., Selzer, J., Aktories, K., & Kalbitzer, H. R. (2003) · Biochemistry · doi:10.1021/bi034529v · Cited by 32
May, M., Wang, T., Müller, M., et al. (2013) · Toxins · doi:10.3390/toxins5010106 · Cited by 31
Filho, A. A. M., de Souza, M. H. L. P., Lyerly, D. M., Cunha, F. Q., Lima, A. Â. M., & Ribeiro, R. A. (1997) · Toxicon · doi:10.1016/s0041-0101(96)00172-9 · Cited by 30
Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A
Cowardin, C. A., Jackman, B. M., Noor, Z., Burgess, S. L., Feig, A. L., & Petri, W. A. (2016) · Infection and Immunity · doi:10.1128/iai.00327-16 · Cited by 29
Jin, K., Wang, S., Zhang, C., Xiao, Y., Lu, S., & Huang, Z. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22434 · Cited by 28
Olling, A., Hüls, C., Goy, S., Müller, M., Krooss, S. A., Rudolf, I., Tatge, H., & Gerhard, R. (2014) · Toxins · doi:10.3390/toxins6072162 · Cited by 27
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection
Fehér, C., Soriano, À., & Mensa, J. (2016) · Infectious Diseases and Therapy · doi:10.1007/s40121-016-0140-z · Cited by 23
An update on antibody-based immunotherapies for Clostridium difficile infection
Tanha, J., & Hussack, G. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s84017 · Cited by 22
Müller, S., von Eichel‐Streiber, C., & Moos, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00951.x · Cited by 21
FDA approves antitoxin antibody
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.257 · Cited by 21
Chavez, C. V., Hoos, S., Haustant, M., Chenal, A., England, P., Blondel, A., Pauillac, S., Lacy, D. B., & Popoff, M. R. (2015) · Cellular Microbiology · doi:10.1111/cmi.12449 · Cited by 19
Self-citationD’Auria, K. M., Bloom, M. J., Reyes, Y., Gray, M. C., van Opstal, E. J., Papin, J. A., & Hewlett, E. L. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0361-4 · Cited by 18
Zhang, Y., Hamza, T., Gao, S., & Feng, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.095 · Cited by 17
Chavez, C. V., Haustant, G., Baron, B., England, P., Chenal, A., Pauillac, S., Blondel, A., & Popoff, M. R. (2016) · Toxins · doi:10.3390/toxins8040090 · Cited by 15
ADP-Ribosylating Binary Toxin Genes ofClostridium difficileStrain CCUG 20309
Chang, S. Y., & Song, K. P. (2001) · DNA sequence · doi:10.3109/10425170109047564 · Cited by 14
Kroh, H. K., Chandrasekaran, R., Rosenthal, K., Woods, R., Jin, X., Ohi, M. D., Nyborg, A. C., Rainey, G. J., Warrener, P., Spiller, B. W., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.781112 · Cited by 14
Self-citationMullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.259 · Cited by 9
Cited by
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics
Kordus, S. L., Thomas, A. K., & Lacy, D. B. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00660-2 · Cited by 204
Self-citation
Metadata
- Authors
- Chandrasekaran, R., & Lacy, D. B.
- Venue
- FEMS Microbiology Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-18
- Volume
- 41
- Issue
- 6
- Pages
- 723-750
- ISSN
- 0168-6445 (ISSN-L)
- 1574-6976
- OpenAlex
- W2765868029
- Cited by
- 353
- References
- 324
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.